EDBI backs $500m Series G investment in biotech firm Moderna Therapeutics

Moderna Therapeutics, a clinical-stage biotechnology firm that develops messenger RNA (mRNA) therapeutics and vaccines, has secured $500 million in a round participated by Singapore-based EDBI and Sequoia Capital China, it announced in a release.

Continue reading this story with a subscription to DealStreetAsia.


Contact us for corporate subscriptions at subs@dealstreetasia.com.